Expression of lactoferrin on neutrophil granulocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 30, Issue 2, 2003, Pages 220-224

  Caccavo, Domenico ^a   Garzia, Pierluigi ^b   Sebastiani, Gian Domenico ^c   Ferri, Giovanni Maria ^b   Galluzzo, Sara ^b   Vadacca, Marta ^d   Rigon, Amelia ^d   Afeltra, Antonella ^d   Amoroso, Antonio ^b  

^a UNIVERSITY OF BARI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Lactoferrin; Neutrophil granulocytes; Rheumatoid arthritis; Synovial fluid

Indexed keywords

LACTOFERRIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CELL SURFACE; CYTOFLUOROMETRY; DISEASE ACTIVITY; FEMALE; FLUORESCENCE; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LACTOFERRIN; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; OSTEOARTHRITIS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

EID: 0037308321     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Harris ED. Rheumatoid arthritis pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Brown KA. The polymorphonuclear cell in rheumatoid arthritis. Br J Rheumatol 1988;27:150-5.
3. Kitsis E, Weissmann G. The role of the neutrophil in rheumatoid arthritis. Clin Orthop 1991;265:63-72.
4. Blake DR, Merry P, Unsworth J, et al. Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989;1:289-93.
5. Emery P, Lopez AF, Burns GF, Vadas MA. Synovial fluid neutrophils of patients with rheumatoid arthritis have membrane antigen changes that reflect activation. Ann Rheum Dis 1988;47:34-9.
6. Sanchez L, Calvo M, Brock JH. Biological role of lactoferrin. Arch Dis Child 1992;67:657-61.
7. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995;80:252-67.
8. Masson PL, Heremans JF, Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 1969;130:643-58.
9. Baggiolini M, De Duve C, Masson PL, Heremans JF. Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J Exp Med 1970;131:559-70.
10. Arnold RR, Cole MF, McGhee JR. A bactericidal role for human lactoferrin. Science 1977;197:263-5.
11. Ellison RT III, Giehl TJ. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991;88:1080-91.
12. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. Identification of the bactericidal domain of lactoferrin. Bichim Biophys Acta 1992;1121:130-6.
13. Kirkpatrick CH, Green I, Rich RR, Schade AL. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: Relation to host defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis 1971;124:539-43.
14. Swart PJ, Kuipers EM, Smit C, Van Der Strate BW, Harmsen MC, Meijer DK. Lactoferrin. Antiviral activity of lactoferrin. Adv Exp Med Biol 1998;443:205-13.
15. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 1995;16:417-9.
16. Afeltra A, Caccavo D, Ferri GM, et al. Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin Exp Immunol 1997;109:279-85.
17. Feldmann M, Maini RN. The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 1999;38 Suppl 2:3-7.
18. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Altman R, Asch E, Bloch DA, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
20. Caccavo D, Afeltra A, Guido F, et al. Two spatially distant epitopes of human lactoferrin. Hybridoma 1996;15:263-9.
21. Afeltra A, Sebastiani GD, Galeazzi M, et al. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. J Rheumatol 1996;23:10-5.
22. McKinney MM, Parkinson A. A simple, non chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Methods 1987;96:271-8.
23. Jackson MH, Millar AM, Dawes J, Bell D. Neutrophil activation during cell separation procedures. Nucl Med Commun 1989;10:901-4.
24. Kuijpers TW, Tool AT, van der Schoot CE, et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991;78:1105-11.
25. Felzmann T, Gadd S, Majdic O, et al. Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis. J Clin Immunol 1991;11:205-12.
26. Crockard AD, Thompson JM, McBride SJ, Edgar JD, McNeill TA, Bell AL. Markers of inflammatory activation: upregulation of complement receptors CR1 and CR3 on synovial fluid neutrophils from patients with inflammatory joint disease. Clin Immunol Immunopathol 1992;65:135-42.
27. Jones J, Laffafian I, Cooper AM, Williams BD, Morgan BP. Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis. Br J Rheumatol 1994;33:707-12.
28. Hönig M, Peter HH, Jantscheff P, Grunert F. Synovial PMN show a coordinated up-regulation of CD66 molecules. J Leukoc Biol 1999;66:429-36.
29. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CG. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 1994;98:270-8.
30. Buckle AM, Hogg N. The effect of IFN-γ and colony-stimulating factors on the expression of neutrophil cell membrane receptors. J Immunol 1989;143:2295-301.
31. Neuman E, Hulcatt JW, Jack RM. Granulocyte-macrophage colonystimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils. J Immunol 1990;145:3325-32.
32. Berger M, Wetzler EM, Wallis RS. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood 1988;71:151-8.
33. Ogle JD, Noel JG, Balasurbramaniam A, Sramkoski RM, Ogle CK, Alexander JW. Comparison of abilities of recombinant interleukin-1a and b and noninflammatory IL-1b fragment 163-171 to upregulate C3b receptors (CR1) on human neutrophils and to enhance their phagocytic capacity. Inflammation 1990;14:185-94.
34. Richie ER, Hilliard JK, Gilmore R, Gillespi DJ. Human milk-derived lactoferrin inhibits mitogen and alloantigen induced human lymphocyte proliferation. J Reprod Immunol 1987;12:137-48.
35. Crouch SPM, Slater KJ, Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1992;80:235-40.
36. Machnicki M, Zimecki M, Zagulski T. Lactoferrin regulates the release of tumor necrosis factor alpha and interleukin 6 in vivo. Int J Exp Pathol 1993;74:433-9.
37. Britigan BE, Rosen GM, Thompson BY, Chai Y, Cohen MS. Stimulated human neutrophils limit iron-catalyzed hydroxyl radical formation as detected by spin-trapping techniques. J Biol Chem 1986;261:17026-32.
38. Kievitis F, Kijlstra A. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin. Immunology 1985; 54:449-56.